2 recruiting. .
Follow Sung-Soo Park: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies Bispecific antibody, Antibody-Drug Conjugate, Monoclonal antibody - Multiple Myeloma, Relapsed, Multiple Myeloma (MM) | Recruiting | Sung-Soo Park | 174 | 2025-07-14 | 2025-07-15 | |
| Immunotherapy in Lymphoma CAR-T Therapy, Bispecific antibody, Antibody-Drug Conjugate - Relapsed/refractory High Grade B Cell Lymphoma, High Grade B-cell Lymphoma | Recruiting | Sung-Soo Park | 72 | 2024-06-26 | 2025-01-28 |
Recurrence (2) · Burkitt Lymphoma (1) · Lymphoma, B-Cell (1) · Multiple Myeloma (1)
Antibodies, Bispecific (2) · Antibodies, Monoclonal (2) · Immunoconjugates (2) · Immunotherapy, Adoptive (2) · Proteasome Inhibitors (2)
South Korea (2)